VITALE, Marco

VITALE, Marco  

Dipartimento di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 280 (tempo di esecuzione: 0.13 secondi).
Titolo Data di pubblicazione Autore(i) File
"GIOCAMPUS" - An effective school-based intervention for breakfast promotion and overweight risk reduction. 1-gen-2014 Vanelli, Maurizio; Monti, Giorgia; Volta, Elio; Finestrella, V; Gkliati, Dimitra; Cangelosi, M; Caragnulo, R; Vitale, Marco; Ingrosso, L; Scazzina, Francesca
A cancer-associated, genome protective programme engaging PKCε 1-gen-2020 Parker, P. J.; Lockwood, N.; Davis, K.; Kelly, J. R.; Soliman, T. N.; Pardo, A. L.; Marshall, J. J. T.; Redmond, J. M.; Vitale, M.; Martini, Silvia
A novel surface marker (B203.13) of human haemopoietic progenitors,preferentially expressed along the B and myeloid lineages 1-gen-1998 Zamai, L.; Vitale, Marco; Bennett, I. M.; Croce, C. M.; Perussia, B.
A rapid method for obtaining mesenchymal stem cells and platelets from bonemarrow aspirate 1-gen-2014 Dozza, B.; Gobbi, Giuliana; Lucarelli, E.; Pierini, M.; Bella, C. D.; Frisoni, T.; Tazzari, P. L.; Ricci, F.; Mirandola, Prisco; Carubbi, Cecilia; Giannini, S.; Donati, D.; Vitale, Marco
A role for nuclear phospholipase Cbeta 1 in cell cycle control. 1-gen-2000 Faenza, I.; Matteucci, A.; Manzoli, L.; Billi, A. M.; Aluigi, M.; Peruzzi, D.; Vitale, Marco; Castorina, S.; Suh, P. G.; Cocco, L.
A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1 1-gen-1994 Zauli, G.; Furlini, G.; Vitale, Marco; Re, M. C.; Gibellini, D.; Zamai, L.; Visani, G.; Borgatti, P.; Capitani, S.; LA PLACA, M.
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 1-gen-2008 Gobbi, Giuliana; Mirandola, Prisco; Malinverno, C.; Sponzilli, Ivonne; Carubbi, Cecilia; Ricci, F.; Binazzi, R.; Basso, G.; GIULIANI PICCARI, G.; Ramazzotti, G.; Pasquantonio, G.; Cocco, L.; Vitale, Marco
Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B 1-gen-2010 Nurden, P.; Gobbi, Giuliana; Nurden, A.; Enouf, J.; YOULYOUZ MARFAK, I.; Carubbi, Cecilia; LA MARCA, S.; Punzo, M.; Baronciani, L.; DE MARCO, L.; Vitale, Marco; Federici, A. B.
ABSORBING LYMPHATIC VESSEL OF THE GALT AND LYMPHOCYTE HOMING UNDER NORMAL CONDITIONS AND EXPERIMENTAL INFLAMMATION 1-gen-2010 Arcari, Maria Luisa; Vitale, Marco; Azzali, G.
Activated human NK and CD8+ T cells express both TNF-related apoptosis inducing ligand (TRAIL) and TRAIL receptors, but are resistant to TRAIL-mediated cytotoxicity 1-gen-2004 Mirandola, Prisco; Sponzilli, I.; Gobbi, Giuliana; Ponti, C.; Vitale, Marco
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (trail) and trail receptors but are resistant to trail-mediated cytotoxicity 1-gen-2004 Mirandola, Prisco; Ponti, C.; Gobbi, Giuliana; Sponzilli, Ivonne; Vaccarezza, M.; Cocco, L.; Zauli, G.; Secchiero, P.; Manzoli, F. A.; Vitale, Marco
Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. 1-gen-1990 Mariani, E.; Roda, P.; Mariani, A. R.; Vitale, Marco; Degrassi, A.; Papa, S.; Facchini, A.
Age-related events in active T lymphocyte subpopulation. A morphological study 1-gen-1994 Rana, R.; DI PIETRO, R.; Centurione, L.; Vitale, Marco; Zamai, L.; Sciscio, A.; Mazzotti, G.
Age-related events in active T subpopulation. Changes in polyphosphoinositide metabolism during mitogenic activation. 1-gen-1992 Rana, R.; DI PIETRO, R.; Antonucci, A.; Cataldi, A.; Miscia, S.; Vitale, Marco; Cocco, L.
All-trans retinoic acid shows multiple effects on the survival, proliferation anddifferentiation of human fetal CD34+ haemopoietic progenitor cells 1-gen-1995 Zauli, G.; Visani, G.; Vitale, Marco; Gibellini, D.; Bertolaso, L.; Capitani, S.
Anthropometric outcomes associated with a primary school-based health promotion programme in the Italian city of Parma 1-gen-2012 Galli, Daniela; Volta, E.; Milioli, Maria Adele; Mirandola, Prisco; Vanelli, Maurizio; Brighenti, Furio; Micheloni, Cristina; Vaccarezza, M.; Vitale, Marco; Gobbi, Giuliana
Anti-BrdUrd labeling of newly synthesized DNA in HL-60 cells triggered toapoptosis 1-gen-1996 Zamai, L.; Falcieri, E.; Gobbi, P.; Santi, S.; Falconi, M.; Marhefka, G.; Vitale, Marco
Antiangiogenic activity of the MDM2 antagonist nutlin-3 1-gen-2007 Secchiero, P.; Corallini, F.; Gonelli, A.; Dell'Eva, R.; Vitale, Marco; Capitani, S.; Albini, A.; Zauli, G.
Anticancer agents sensitize osteosarcoma cells to TNF–related apoptosis-inducing ligand downmodulating IAP family proteins 1-gen-2006 Mirandola, Prisco; Sponzilli, Ivonne; Gobbi, Giuliana; Marmiroli, S.; Rinaldi, Laura; Binazzi, R.; Cocco, L.; Vitale, Marco
Antithetic glypican control of cancer growth and dissemination 1-gen-2011 Rossi, S.; Garusi, E.; D'Angelo, A.; Alias, C.; Nicolosi, P. A.; Borsi, L.; Balza, E.; Gatti, Rita; Gobbi, Giuliana; Vitale, Marco; Perris, Roberto